Science

Yüksel Ürün: Longitudinal ctDNA profiling in mCRPC reveals How Tumors Evolve

Yüksel Ürün/X

May 5, 2025, 12:30

Yüksel Ürün: Longitudinal ctDNA profiling in mCRPC reveals How Tumors Evolve

Yüksel Ürün, Medical Oncology professor at Ankara University School of Medicine, shared an article on X:

“Tracking resistance in real time:

Longitudinal ctDNA profiling in mCRPC reveals how tumors evolve.

Greater subclonal shifts seen with AR-targeted therapy vs taxanes.
Emerging clones enriched for PI3K-AKT alterations.”

Longitudinal Profiling of Circulating Tumor DNA Reveals the Evolutionary Dynamics of Metastatic Prostate Cancer during Serial Therapy.

Authors: Yuehui Zhao, Naveen Ramesh, Ping Xu, Emi Sei, Min Hu, Shanshan Bai, Patricia Troncoso, Ana M. Aparicio, Christopher J. Logothetis, Paul G. Corn, Nicholas E. Navin, Amado J. Zurita.

You can read the Full Article on Journal of American Association of Cancer Research.

Yüksel Ürün: Longitudinal ctDNA profiling in mCRPC reveals How Tumors Evolve

More posts featuring Yüksel Ürün.

Amado J Zurita Ana M. Aparicio Ankara University School of Medicine cancer Christopher J Logothetis Circulating tumor DNA Emi Sei fight against cancer Global fight against cancer Longitudinal ctDNA profiling mCRPC MedOnc metastatic prostate cancer Min Hu Naveen Ramesh Nicholas E. Navin OncoDaily Oncology Patricia Troncoso Paul G Corn PI3K-AKT Ping Xu prostate cancer Shanshan Bai targeted therapy taxanes Yuehui Zhao Yüksel Ürün

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action

King Hussein Cancer Research Award: Don’t Miss Your Chance to Apply